BrainStorm Cell Therapeutics
BCLI
#10103
Rank
A$11.35 M
Marketcap
$1.74
Share price
14.87%
Change (1 day)
-85.94%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.89

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.92. In 2022 the company made an earnings per share (EPS) of -$1.03 an increase over its 2021 EPS that were of -$1.06.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.89-13.48%
2022-$1.03-2.94%
2021-$1.06-37.04%
2020-$1.681.89%
2019-$1.6551.43%
2018-$1.09159.26%
2017-$0.42-3.57%
2016-$0.44-37.78%
2015-$0.70-33.82%
2014-$1.0636%
2013-$0.7811.11%
2012-$0.7050%
2011-$0.47-50%
2010-$0.93-233.33%
2009$0.70-142.86%
2008-$1.63-65%
2007-$4.66
2005$1.54-108.03%
2004-$19.1713203.07%
2003-$0.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$6.82-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.84 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.23 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$28.69-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.32 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA